Selatogrel
Tier C — Watch / tradeSelatogrel
Targets：P2RY12
Indications (approved)：Myocardial infarction, 慢性冠脉综合征, Hepatic function decline, Coronary artery lesion
Regional status
Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| ACT-246475 | - | - |
| ACT-246475-001 | 93267-04-0Available | (R)-methyl 2-((tert-butoxycarbonyl)amino)-3-iodopropanoate |
| ACT-246475-002 | 851475-17-7 | (R)-methyl 2-((tert-butoxycarbonyl)amino)-3-(diethoxyphosphoryl)propanoate |
| ACT-246475-003 | 1159501-66-2 | (R)-2-((tert-butoxycarbonyl)amino)-3-(diethoxyphosphoryl)propanoic acid |
| ACT-246475-004 | 50606-32-1 | butyl piperazine-1-carboxylate |
| ACT-246475-005 | 1159501-70-8 | (R)-butyl 4-(2-((tert-butoxycarbonyl)amino)-3-(diethoxyphosphoryl)propanoyl)piperazine-1-carboxylate |
| ACT-246475-006 | 1159501-71-9 | (R)-butyl 4-(2-amino-3-(diethoxyphosphoryl)propanoyl)piperazine-1-carboxylate hydrochloride |
| ACT-246475-007 | 1159501-69-5 | (S)-6-(3-methoxypyrrolidin-1-yl)-2-phenylpyrimidine-4-carboxylic acid |
| ACT-246475-008 | 1159501-72-0 | butyl 4-((R)-3-(diethoxyphosphoryl)-2-(6-((S)-3-methoxypyrrolidin-1-yl)-2-phenylpyrimidine-4-carboxamido)propanoyl)piperazine-1-carboxylate |
| ACT-246475-009 | 592-34-7 | butyl carbonochloridate |
| ACT-246475-010 | 2759-28-6 | 1-benzylpiperazine |
| ACT-246475-011 | 1019928-96-1 | butyl 4-benzylpiperazine-1-carboxylate |
| ACT-246475-012 | 100243-39-8 | (S)-pyrrolidin-3-ol |
| ACT-246475-013 | 101469-92-5 | (S)-tert-butyl 3-hydroxypyrrolidine-1-carboxylate |
| ACT-246475-014 | 550371-69-2 | (S)-tert-butyl 3-methoxypyrrolidine-1-carboxylate |
| ACT-246475-015 | 685828-16-4 | (S)-3-methoxypyrrolidine hydrochloride |
| ACT-246475-016 | 913952-59-7 | 6-chloro-2-phenylpyrimidine-4-carboxylic acid |
| ACT-246475-017 | 1875708-16-9 | 6-(methoxymethyl)-2-phenylpyrimidin-4-ol |
| ACT-246475-018 | 325685-59-4 | 4-chloro-6-(methoxymethyl)-2-phenylpyrimidine |
| ACT-246475-019 | 325685-75-4 | (6-chloro-2-phenylpyrimidin-4-yl)methanol |
Frequently asked questions
What are the approved indications of Selatogrel?
Approved indications include: Myocardial infarction, 慢性冠脉综合征, Hepatic function decline, Coronary artery lesion.
When does the Selatogrel patent expire?
No public expiry year is available for Selatogrel yet; this page updates once verified.
How many synthesis routes are recorded for Selatogrel?
1 synthesis routes are recorded; the shortest is 15 steps with / total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Selatogrel intermediates?
1 intermediate CAS of Selatogrel are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.
How do I get a quote for Selatogrel intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-06